Emry Lloyd

Conference Coverage
Evaluation of a Medication Acquisition Program for Patient Access to Off-Label Treatment
06/21/2023
Researchers analyzed the success of their institution’s medication acquisition program for patients with cancer, including tracking clinical benefit.
Researchers analyzed the success of their institution’s medication acquisition program for patients with cancer, including tracking clinical benefit.
Researchers analyzed the success...
06/21/2023
Journal of Clinical Pathways
News
Analysis of Outcomes for Patients With CLL Disease Progression While on Ibrutinib
09/14/2023
In a recent analysis, researchers investigated the factors that contribute to worse outcomes for patients with CLL who experience disease progression while on ibrutinib.
In a recent analysis, researchers investigated the factors that contribute to worse outcomes for patients with CLL who experience disease progression while on ibrutinib.
In a recent analysis,...
09/14/2023
Journal of Clinical Pathways
News
FDA Approves Momelotinib for Patients With Anemia and Myelofibrosis
10/27/2023
On September 15, 2023, the FDA approved momelotinib for the treatment of adult patients with myelofibrosis and anemia.
On September 15, 2023, the FDA approved momelotinib for the treatment of adult patients with myelofibrosis and anemia.
On September 15, 2023, the FDA...
10/27/2023
Journal of Clinical Pathways
News
Progression-Free Survival Benefits of Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone For Multiple Myeloma
01/31/2024
Daratumumab, bortezomib, lenalidomide, and dexamethasone have shown significant results in progression-free survival rates for patients with newly diagnosed multiple myeloma.
Daratumumab, bortezomib, lenalidomide, and dexamethasone have shown significant results in progression-free survival rates for patients with newly diagnosed multiple myeloma.
Daratumumab, bortezomib,...
01/31/2024
Journal of Clinical Pathways
Conference Coverage
The Impact of Health Care Industry Consolidation on Cancer Care and Partnerships
10/08/2023
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny,...
10/08/2023
Journal of Clinical Pathways
News
How Clinical Pathways Can be Used For HER2-Positive Breast Cancer Therapies
10/07/2023
At CPC & CBEx 2023, Sayeh Lavasani, MD, discussed the different ways clinical pathways can be followed for HER2-positive breast cancer therapies.
At CPC & CBEx 2023, Sayeh Lavasani, MD, discussed the different ways clinical pathways can be followed for HER2-positive breast cancer therapies.
At CPC & CBEx 2023, Sayeh...
10/07/2023
Journal of Clinical Pathways
News
How to Incorporate Inclusivity into Care For LGBTQ+ Residents in Nursing Homes
12/14/2023
In a new study, Jennifer L. Carnahan, MD, from the Indiana University School of Medicine, and her colleagues from the Regenstief Institute found that very few studies are available on the quality of life and care of LGBTQ+ residents living in...
In a new study, Jennifer L. Carnahan, MD, from the Indiana University School of Medicine, and her colleagues from the Regenstief Institute found that very few studies are available on the quality of life and care of LGBTQ+ residents living in...
In a new study, Jennifer L....
12/14/2023
Annals of Long-Term Care
News
A Look at the Updates in the NCCN Clinical Practice Guidelines For Prostate Cancer
02/09/2024
Get a summary of the changes in the NCCN guidelines regarding radiopharmaceuticals, secondary hormone therapy, and treatments for metastatic castration-sensitive prostate cancer.
Get a summary of the changes in the NCCN guidelines regarding radiopharmaceuticals, secondary hormone therapy, and treatments for metastatic castration-sensitive prostate cancer.
Get a summary of the changes in...
02/09/2024
Journal of Clinical Pathways
Frederick Schnell, MD, Nicolas Ferreyros, and Barbara McAneny, MD, discuss health care advocacy and policy at CPC & CBEx 2023
News
How Congress Plans to Address Patient and Hospital Challenges, and How This Could Affect Oncologists
10/10/2023
At CPC & CBEx 2023, Barbara McAneny, MD, Nicolas Ferreyros, and Frederick Schnell, MD, shared insight into Congress’s plan to address specific patient and hospital concerns, and how it might affect oncologists.
At CPC & CBEx 2023, Barbara McAneny, MD, Nicolas Ferreyros, and Frederick Schnell, MD, shared insight into Congress’s plan to address specific patient and hospital concerns, and how it might affect oncologists.
At CPC & CBEx 2023, Barbara...
10/10/2023
Journal of Clinical Pathways
News
A Deeper Look Into Hypertension and Cardiovascular Toxicity Symptoms for Patients Treated With Ibrutinib
10/13/2023
Max Gordon, MD, and colleagues evaluated the long-term effects in patients with chronic lymphocytic leukemia who reported hypertension or cardiovascular issues while receiving ibrutinib.
Max Gordon, MD, and colleagues evaluated the long-term effects in patients with chronic lymphocytic leukemia who reported hypertension or cardiovascular issues while receiving ibrutinib.
Max Gordon, MD, and colleagues...
10/13/2023
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use